1. Home
  2. HALO vs PCOR Comparison

HALO vs PCOR Comparison

Compare HALO & PCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$107.93

Market Cap

12.0B

Sector

Health Care

ML Signal

N/A

Logo Procore Technologies Inc.

PCOR

Procore Technologies Inc.

N/A

Current Price

$52.11

Market Cap

9.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
PCOR
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
9.6B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
HALO
PCOR
Price
$107.93
$52.11
Analyst Decision
Buy
Buy
Analyst Count
9
24
Target Price
★ $99.56
$68.19
AVG Volume (30 Days)
2.0M
★ 2.2M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.94
EPS
★ 3.11
0.05
Revenue
$151,862,000.00
★ $1,322,509,000.00
Revenue This Year
$32.72
$14.50
Revenue Next Year
$10.61
$13.30
P/E Ratio
★ $36.16
$993.80
Revenue Growth
N/A
★ 14.83
52 Week Low
$61.23
$38.03
52 Week High
$116.85
$82.32

Technical Indicators

Market Signals
Indicator
HALO
PCOR
Relative Strength Index (RSI) 54.81 48.31
Support Level $104.49 $45.91
Resistance Level $111.15 $55.55
Average True Range (ATR) 3.04 2.08
MACD -0.71 -0.06
Stochastic Oscillator 42.53 57.50

Price Performance

Historical Comparison
HALO
PCOR

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About PCOR Procore Technologies Inc.

Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.

Share on Social Networks: